Scientific sessions presented research findings on obesity, diabetes technology, AI health and the latest innovations in diabetes care.
Dr. Robert Gabbay, ADA Chief Scientific and Medical Officer, explains: "This year's program reflects our commitment to advancing research, fostering innovation and ultimately improving the lives of those affected by diabetes."
We are delighted that our scientists (left to right: Leontine Sandforth, Arvid Sandforth, Reiner Jumpertz-von Schwartzenberg, Sara Katzenstein, Simon Dreher) have contributed to this important international conference with their latest research findings in presentations and posters.
About the ADA:
The ADA is a large voluntary health organization dedicated to preventing and curing diabetes. For more information, visit diabetes.org.
IDM researchers participate in the 84th ADA Scientific Sessions
IDM